Large-scale testing (Phase 3)Study completedNCT01047553
What this trial is testing
Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients
Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 251